Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Patient Support Specialist Job
Celgene Corporation - Berkeley Heights, NJ, US
Partner
Lundbeckfond Ventures - Copenhagen, Denmark
Analyst, Procurement Operations Job
Celgene Corporation - Basking Ridge, NJ, US
Hematology Oncology Consultant, Hematology - Louisiana North Job
Celgene Corporation - Louisiana, LA, US
Principal Scientist
Watson Pharmaceuticals - Fort Lauderdale, FL

More Jobs >>

Events

Biomarker Applications for Improved Clinical Trial Outcomes
Nov. 15-16 — Boston
Partnerships in Clinical Trials 2012
March 4-7 — Orlando, FL
Pharmacovigilance and Risk Management Strategies 2012
January 22-25, 2012 — Arlington, Virginia
Just Released: New Trends in Preventive and Therapeutic Vaccine

More Events >>

Related Tags >> Cervarix GlaxoSmithKline

clinical data News

Most Popular clinical data Story

Glaxo touts proof of Cervarix's wider efficacy

July 8, 2009 — 11:58am ET | By John Carroll

GlaxoSmithKline continues to build a convincing case for Cervarix. The pharma giant reports that a new study shows that the cervical cancer vaccine is effective against the five most common viruses Read more...

clinical data Press Releases

Clinical Data, Inc. Announces FDA Approval of ViibrydTM (vilazodone HCl) for Major Depressive Disorder
BN ImmunoTherapeutics Reports Further Data on PROSTVAC(TM)
Alnylam Presents Pre-clinical Data from TTR Amyloidosis Development Program
ZIOPHARM Oncology Presents Positive Data from Studies of Palifosfamide
Patients Experienced Nearly a 70% Reduction in Pain When Using MPM Medical's Regenecare Wound Care Gel

Latest Headlines

Glaxo touts proof of Cervarix's wider efficacy
July 8, 2009

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK